Add BrightSurf on Google Email

Journal of the National Cancer Institute


Other Highlights in the Nov. 27 JNCI

Male BRCA1 and BRCA2 mutation carriers have a higher risk of developing breast cancer compared to noncarriers. A high carbohydrate diet may also promote prostate tumor growth in mice, while infection with human papillomavirus (HPV) is associated with an increased risk of head and neck cancers but does not further increase the risk when...

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateNov 27, 2007

Other highlights in the Nov. 13 JNCI

A new model for predicting estrogen receptor-positive breast cancer risk in postmenopausal women performs almost as well as the standard Gail model and could be used to identify high-risk women. Smoking is associated with rectal cancer, while drugs like ZD6126 may cause heart damage due to cardiovascular changes.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateNov 13, 2007

Vitamin A derivative associated with reduced growth in some lung cells

A study published in the Journal of the National Cancer Institute found that treatment with a vitamin A derivative called retinoic acid reduced the growth of lung cells in former heavy smokers. The researchers also found that the treatment slowed down cell growth in the parabasal layer of lung cells, but not in the basal layer.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateOct 30, 2007

Higher education is associated with lower cancer death rate

A study published in the Journal of the National Cancer Institute found that higher education levels are associated with decreased cancer mortality rates among black and white men and women. The difference in mortality was greatest between those with 12 or fewer years of education and those with more than 12 years. This association is ...

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateSep 11, 2007

Hypnosis reduces pain and costs in breast cancer surgery

A recent study published in the Journal of the National Cancer Institute found that hypnosis prior to breast cancer surgery reduced the amount of anesthesia used during the operation, as well as levels of pain and other side effects reported afterwards. This resulted in shorter hospital stays, fewer readmissions, and lower surgical costs.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateAug 28, 2007

Other highlights in the Aug. 28 JNCI

Researchers identify specific H. pylori strains associated with precancerous gastric lesions, potentially underestimating the risk of gastric cancer. Meanwhile, a gene called OGR1 is found to suppress prostate cancer metastasis in mice, suggesting its potential as a novel metastasis suppressor gene.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateAug 28, 2007

Other highlights in the Aug. 7 JNCI

Researchers found that taking vitamins and minerals did not reduce liver cancer death rates in a study conducted by the National Cancer Institute. However, some vitamin-mineral combinations reduced risk in subgroups defined by age, sex, and alcohol consumption. In contrast, gene expression patterns identified 11 genes in noncancerous l...

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateAug 7, 2007

Chemotherapy with bevacizumab increases risk of blood clots in arteries

A study published in the Journal of the National Cancer Institute found that chemotherapy with bevacizumab increases the risk of blood clots in arteries, with a higher incidence among patients over 65 years old. The risk of arterial thromboembolic events was significantly higher in patients treated with the combination therapy compared...

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateAug 7, 2007

Success rates for prostate cancer depend on experience of surgeon

A study published in the Journal of the National Cancer Institute found that experienced surgeons perform more successful prostate cancer surgeries, with a steeper learning curve. As surgeons gain experience, patient outcomes improve, but beyond 250 operations, additional experience has little influence on cancer recurrence rates.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJul 24, 2007

Other highlights from the July 10 JNCI

Researchers developed a new drug delivery method using ultrasound to target cancer tumors, releasing chemotherapy drugs from nanobubbles. They found this approach was more effective at blocking tumor growth than other nanoparticle delivery methods. Vitamin D levels were also associated with reduced colon cancer risk in a separate study.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJul 10, 2007

FDA finds no strong link between tomatoes and reduced cancer risk

The FDA review found no strong association between eating tomatoes and decreased cancer risk, but some limited evidence for associations with prostate, ovarian, gastric, and pancreatic cancers. The agency allowed qualified health claims for these four cancers, citing very limited and preliminary scientific research.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJul 10, 2007

BRCA2 carriers at increased risk for deadly form of prostate cancer

BRCA2 mutation carriers have a higher risk of developing aggressive and lethal prostate cancer, with younger onset and advanced-stage disease, according to a study published in the Journal of the National Cancer Institute. The study suggests that studying gene expression patterns in prostate cancers may help predict progression.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJun 12, 2007

Other highlights in JNCI, June 12

Recent studies found a decline in Kaposi sarcoma and non-Hodgkin lymphoma incidence among AIDS patients treated with HAART, associated with increased CD4 cell counts. Additionally, researchers identified the CCRK gene as potentially involved in glioblastoma multiforme development.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJun 12, 2007

Other highlights from the June 6 JNCI

A prospective study found that aspirin use was associated with lower risk of cancer incidence and mortality, particularly among former and non-smokers. In contrast, integrin α7 gene mutations were identified in various cancers, including prostate and liver cancer, suggesting a potential role in cancer development.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJun 5, 2007

New algorithms classify outcomes of nonsmall cell lung cancer patients

Two research teams developed models to predict NSCLC patient outcomes based on protein patterns. The new models, validated in independent groups, could help physicians decide treatment options for patients with NSCLC. Researchers identified a 25-signature proteomic signature associated with increased survival among NSCLC patients.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJun 5, 2007

Other highlights in the May 2 JNCI

Researchers have confirmed that tamoxifen prevents breast cancer in high-risk women, while a combination of three HER inhibitors slows down tumor growth. Additionally, chemotherapy with rituximab improves overall survival rates for patients with indolent lymphoma, and new lung cancer risk prediction models offer modest accuracy.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateMay 1, 2007

Study finds no survival benefit for gastric cancer patients

A randomized controlled trial of high-risk gastric cancer patients showed no significant difference in survival between two treatment groups. The five-year survival rate was around 50%, higher than previous studies, suggesting that the quality of surgery and potential toxicity of postoperative chemotherapy may be factors.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateApr 17, 2007